IP Library Granted Patent US 7,759,094
Granted Patent B2
US 7,759,094 · App. 11/658,477 · Granted Jul 20, 2010

Method for the production of L-amino acids using strains from the Enterobacteriaceae family which contain an enhanced lamb gene

Assignee: Degussa GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,759,094
App. No.
11/658,477
Granted
Jul 20, 2010
Kind
B2
Abstract

The invention relates to a method for the production of L-amino acids by fermentation of recombinant microorganisms of the Enterobacteriaceae family, characterized in that a) the microorganisms producing the desired L-amino acid and wherein the lamB-gene or nucleotide sequence coding for the gene product maltoporin is amplified, particularly overexpressed, are cultivated in a medium in conditions enabling the desired L-amino acid to be enriched in the medium or in cells, and b) the desired L-amino acid is isolated, wherein constituents of the fermentation broth and/or biomass remain in the entirety thereof or in parts thereof (=0 bis 100%) in the isolated product or are fully removed.

Claims (76)

1. A recombinant microorganism of the family Enterobacteriaceae which, relative to the corresponding nonrecombinant microorganism:

a) comprises a lamB gene which is amplified or overexpressed by increasing the copy number of the lamB gene or by putting the lamB gene under the control of a strong promoter; and wherein said lamB gene codes for a polypeptide which:

i) has at least 90% sequence identity to the amino acid sequence of SEQ ID NO:4; and

ii) has maltoporin activity;

(b) further comprises at least one gene in a biosynthesis pathway of an L-amino acid that is amplified or overexpressed: and

(c) produces an increased amount of L-amino acids.

2. The recombinant microorganism of claim 1 , wherein said polypeptide comprises an amino acid sequence at least 9500 identical to the sequence of SEQ ID NO:4.

3. The recombinant microorganism of claim 1 , wherein said polypeptide comprises an amino acid sequence identical to that of SEQ ID NO:4.

4. The recombinant microorganism of claim 1 , produced by transformation, transduction, conjugation or a combination of these methods using a vector which comprises the lamB gene, or an allele of this gene and a promoter that is operably linked to said gene or said allele.

5. The recombinant microorganism of claim 1 , wherein the number of copies of said lamB gene is increased by at least 1.

6. The recombinant microorganism of claim 5 , wherein the number of copies of the lamB gene is increased by integration of the lamB gene into the chromosome of a microorganism.

7. The recombinant microorganism of claim 5 , wherein the number of copies of the lamB gene is increased by a vector replicating extrachromosomally.

8. The recombinant microorganism of claim 1 , wherein said lamB gene is under the control of a promoter amplifying the expression of the gene.

9. The recombinant microorganism of claim 1 , wherein the concentration or activity of the lamB gene product is increased by at least 10%, relative to the corresponding non-recombinant starting strain.

10. The recombinant microorganism of claim 1 , wherein said recombinant microorganism is selected from the group of genera consisting of: Escherichia, Erwinia, Providencia and Serratia.

11. The recombinant microorganism of claim 1 , wherein one of said amino acids is L-threonine.

12. The recombinant microorganism of claim 11 , produced by transformation, transduction, conjugation or a combination of these methods using a vector which comprises the lamB gene or an allele of this gene and a promoter that is operably linked to said gene or said allele.

13. A method for producing a desired L-amino acid by fermentation, comprising:

a) culturing a recombinant microorganism of the family Enterobacteriaceae that produces the desired L-amino acid and wherein:

i) relative to the corresponding nonrecombinant microorganism, said recombinant microorganism overexpresses a lamB gene or a polynucleotide coding for a polypeptide which is at least 9000 sequence identical to the polypeptide of SEQ ID NO:4 and wherein said polypeptide has maltoporin activity;

ii) said culturing is performed in a medium and under conditions in which the desired L-amino acid is enriched in the medium or in the cells, and

b) isolating the desired L-amino acid along with 0 to 100% of the components of the fermentation broth and/or the biomass.

14. The method of claim 13 , wherein said desired L-amino acid is L-threonine, and wherein, in addition to lamB, said recombinant microorganism comprises at least one additional gene that is amplified or overexpressed, said additional gene being selected from the group consisting of:

a) at least one gene of the thrABC operon coding for aspartate kinase, homoserine dehydrogenase, homoserine kinase and threonine synthase,

b) the pyc gene of Corynebacterium glutamicum coding for pyruvate carboxylase,

c) the pps gene coding for phosphoenolpyruvate synthase,

d) the ppc gene coding for phosphoenolpyruvate carboxylase,

e) the genes pntA and pntB coding for the subunits of pyridine transhydrogenase,

f) the gene rhtB coding for the protein conferring homoserine resistance,

g) the gene rhtC coding for the protein conferring threonine resistance,

h) the thrE gene from Corynebacterium glutamicum coding for the threonine-export-carrier protein,

i) the gdhA gene coding for glutamate dehydrogenase,

j) the pgm gene coding for phosphoglucomutase,

k) the fba gene coding for fructose biphosphate aldolase,

l) the ptsH gene coding for phosphohistidine protein hexose phosphotransferase,

m) the ptsI gene coding for enzyme I of the phosphotransferase system,

n) the crr gene coding for the glucose-specific IIA component,

o) the ptsG gene coding for the glucose-specific IIBC component,

p) the 1rp gene coding for the regulator of the leucine regulon,

q) the fadR gene coding for the regulator of the fad regulon,

r) the iclR gene coding for the regulator of central intermediate metabolism,

s) the ahpC gene coding for the small subunit of alkyl hydroperoxide reductase,

t) the ahpF gene coding for the large subunit of alkyl hydroperoxide reductase,

u) the cysK gene coding for cysteine synthase A,

v) the cysB gene coding for the regulator of the cys regulon,

w) the cysJ gene coding for the flavoprotein of NADPH sulfite reductase,

x) the cysI gene coding for the hemoprotein of NADPH sulfite reductase,

y) the cysH gene coding for adenylylsulfate reductase,

z) the rseA gene coding for a membrane protein having anti-sigmaE activity,

aa) the rseC gene coding for a global regulator of the sigmaE factor,

bb) the sucA gene coding for the decarboxylase subunit of 2-ketoglutarate dehydrogenase,

cc) the sucB gene coding for the dihydrolipoyltranssuccinase E2 subunit of 2-ketoglutarate dehydrogenase,

dd) the sucC gene coding for the β-subunit of succinyl-CoA synthetase,

ee) the sucD gene coding for the α-subunit of succinyl-CoA synthetase,

ff) the E gene coding for the E1 component of the pyruvate dehydrogenase complex,

gg) the aceF gene coding for the E2 component of the pyruvate dehydrogenase complex,

hh) the rseB gene coding for the regulator of SigmaE factor activity,

ii) the malT gene coding for the positive transcriptional regulator of the maltose regulon,

jj) the gene product of the open reading frame (ORF) yaaU of Escherichia coli,

kk) the gene product of the open reading frame (ORF) yodA of Escherichia coli and

ll) the gene product of the open reading frame (ORF) yibD of Escherichia coli.

15. The method of claim 13 , wherein said recombinant microorganism further comprises at least one metabolic pathway which reduces the formation of the desired L-amino acid that is at least in part attenuated.

16. The method of claim 15 , wherein said desired L-amino acid is L-threonine, and wherein said recombinant microorganism comprises at least one gene that is disrupted, said additional one gene being selected from the group consisting of:

a) the tdh gene coding for threonine dehydrogenase,

b) the mdh gene coding for malate dehydrogenase,

c) the gene product of the open reading frame (ORF) yjfA of Escherichia coli,

d) the gene product of the open reading frame (ORF) ytfP of Escherichia coli,

e) the pckA gene coding for phosphoenolpyruvate carboxykinase,

f) the poxB gene coding for pyruvate oxidase,

g) the dgsA gene coding for the DgsA regulator of the phosphotransferase system,

h) the fruR gene coding for the fructose repressor,

i) the rpoS gene coding for the Sigma 38 factor, and

j) the aspA gene coding for aspartate ammonium lyase.

17. The method of claim 13 , wherein said desired L-amino acid is selected from the group consisting of: L-asparagine, L-serine, L-glutamate, L-glycine, L-alanine, L-cysteine, L-valine, L-methionine, L-proline, L-isoleucine, L-leucine, L-tyrosine, L-phenylalanine, L-histidine, L-lysine, L-tryptophan, L-arginine and L-homoserine.

18. The method of claim 13 , wherein said desired L-amino acid is L-threonine.

19. The method of claim 18 , wherein said recombinant microorganism is produced by transformation, transduction, conjugation or a combination of these methods using a vector which comprises the lamB gene or an allele of this gene and a promoter that is operably linked to said gene or said allele.

Assignments (5)
CHANGE OF NAME Recorded Feb 1, 2020
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 051776/0710 →
CHANGE OF NAME Recorded Feb 23, 2010
From: DEGUSSA GMBH
To: EVONIK DEGUSSA GMBH
Reel/Frame 024006/0127 →
CHANGE ADDRESS Recorded Feb 22, 2010
From: EVONIK DEGUSSA GMBH
To: EVONIK DEGUSSA GMBH
Reel/Frame 023985/0296 →
CHANGE OF ENTITY Recorded Feb 22, 2010
From: DEGUSSA AG
To: DEGUSSA GMBH
Reel/Frame 023998/0937 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2007
From: RIEPING, MECHTHILD
To: DEGUSSA GMBH
Reel/Frame 019026/0142 →
Priority Claims (1)
DE 10 2004 037 572 · Aug 3, 2004 · national
Continuity (1)
Related Publication 20090068711A1 · Mar 12, 2009